How loss of key protein promotes aggressive form of leukaemia
July 2nd, 2010 - 2:50 pm ICT by ANIWashington, July 2 (ANI): A new research shows how the absence of an important tumour-suppressing protein gives rise to acute myeloid leukaemia (AML).
CSHL Professor Scott W. Lowe. Ph.D., an Investigator of the Howard Hughes Medical Institute and colleagues found that disabling protein P53 combined with a genetic mutation caused cell proliferation.
P53 has the ability to induce a cell to commit suicide (apoptosis) or to enter a quiescent state in which it can no longer multiply (senescence). So its absence causes a cell’s “braking” system to be disabled.
“We showed that it has the ability to reinforce cell-fate and differentiation programs. In AML, p53 loss leads to cancer by disabling this reinforcement. The question we are now eager to answer is whether p53 has similar functions in other types of cancer,” said Johannes Zuber, M.D.
The results are published in the July 1 issue of Genes & Development. (ANI)
- Small molecule may deactivate enemy of cancer-fighting p53 - Dec 08, 2010
- Fish oil may hold key to leukaemia cure - Dec 23, 2011
- Cancer cells' survival mechanism identified - Apr 27, 2011
- New way to kill cancer cells discovered - Sep 18, 2011
- New 'poison' discovery could pave way for leukaemia therapy - Dec 04, 2010
- Gene mutation behind onset of acute myeloid leukaemia identified - Mar 28, 2011
- Scientists identify human body's natural defenses against cancer - Dec 12, 2009
- Protein that contributes to ulcerative colitis revealed - Apr 02, 2011
- Gene that prevents stem cells from turning cancerous identified - Oct 15, 2010
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- Mechanism limiting scar formation discovered - Jun 11, 2010
- New treatment for acute myeloid leukaemia developed - Jul 07, 2009
- Sunscreen chemical may cause cancer - Dec 01, 2011
- Protein aggregation plays significant role in cancer development - Mar 30, 2011
- New therapeutic target for leukaemia identified - Jan 28, 2010
Tags: acute myeloid, aml, apoptosis, braking system, cell fate, cell proliferation, cshl, differentiation, genetic mutation, howard hughes, howard hughes medical, howard hughes medical institute, hughes medical institute, myeloid leukaemia, professor scott, protein p53, quiescent state, reinforcement, types of cancer, zuber